Found: 112
Select item for more details and to access through your institution.
Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
- Published in:
- Genes, Chromosomes & Cancer, 2007, v. 46, n. 5, p. 494, doi. 10.1002/gcc.20433
- By:
- Publication type:
- Article
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1620, doi. 10.1002/ajh.27367
- By:
- Publication type:
- Article
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1192, doi. 10.1002/ajh.27304
- By:
- Publication type:
- Article
Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E47, doi. 10.1002/ajh.26411
- By:
- Publication type:
- Article
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1002, doi. 10.1002/ajh.25561
- By:
- Publication type:
- Article
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. E239, doi. 10.1002/ajh.23841
- By:
- Publication type:
- Article
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 34, doi. 10.1159/000443906
- By:
- Publication type:
- Article
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 4, p. 185, doi. 10.1159/000381524
- By:
- Publication type:
- Article
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
- Published in:
- Oncogene, 1998, v. 16, n. 14, p. 1891, doi. 10.1038/sj.onc.1201764
- By:
- Publication type:
- Article
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 9, p. 1984, doi. 10.1002/ijc.22929
- By:
- Publication type:
- Article
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 5, p. 978, doi. 10.1002/ijc.22752
- By:
- Publication type:
- Article
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 7, p. 1831, doi. 10.1002/ijc.21502
- By:
- Publication type:
- Article
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 4, p. 474, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C
- By:
- Publication type:
- Article
BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN -like.
- Published in:
- International Journal of Cancer, 2000, v. 88, n. 5, p. 692, doi. 10.1002/1097-0215(20001201)88:5<692::AID-IJC2>3.0.CO;2-3
- By:
- Publication type:
- Article
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
- By:
- Publication type:
- Article
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
- By:
- Publication type:
- Article
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 7, p. 1, doi. 10.1038/s41419-024-06864-7
- By:
- Publication type:
- Article
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41419-019-1801-0
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, and rituximab as first‐line treatment in patients with chronic lymphocytic leukemia: A long‐term analysis of the German CLL Study Group (GCLLSG) registry.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 235, doi. 10.1111/ejh.14220
- By:
- Publication type:
- Article
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 3, p. 254, doi. 10.1111/ejh.12825
- By:
- Publication type:
- Article
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E36, doi. 10.3816/CLM.2009.n.098
- By:
- Publication type:
- Article
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019.
- Published in:
- Intensive Care Medicine Experimental, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40635-021-00409-4
- By:
- Publication type:
- Article
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study.
- Published in:
- HIV Medicine, 2022, v. 23, n. 5, p. 564, doi. 10.1111/hiv.13207
- By:
- Publication type:
- Article
Adjuvant Therapy of High-Risk (Stages IIC–IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.637161
- By:
- Publication type:
- Article
Telomere Dysfunction in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.612665
- By:
- Publication type:
- Article
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.604685
- By:
- Publication type:
- Article
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.580364
- By:
- Publication type:
- Article
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01578
- By:
- Publication type:
- Article
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00210-6
- By:
- Publication type:
- Article
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 526, p. 1, doi. 10.1126/scitranslmed.aax9340
- By:
- Publication type:
- Article
P53 and microRNAs in chronic lymphocytic leukemia.
- Published in:
- Journal of Nucleic Acids Investigation, 2011, v. 2, n. 1-3, p. 43, doi. 10.4081/jnai.2011.2414
- By:
- Publication type:
- Article
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-00724-7
- By:
- Publication type:
- Article
Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasms – a practical guide to WHO HAEM5.
- Published in:
- Medizinische Genetik, 2024, v. 36, n. 1, p. 47, doi. 10.1515/medgen-2024-2006
- By:
- Publication type:
- Article
First Demonstration of Leukemia Imaging with The Proliferation Marker <sup>18</sup>F-Flourodeoxythymidine.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1756, doi. 10.2967/jnumed.108.055335
- By:
- Publication type:
- Article
Bone Marrow Transplantation Nephropathy after an Intensified Conditioning Regimen with Radioimmunotherapy and Allogeneic Stem Cell Transplantation.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 2, p. 278
- By:
- Publication type:
- Article
Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion.
- Published in:
- Cellular & Molecular Biology Letters, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s11658-024-00609-2
- By:
- Publication type:
- Article
Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genesSequence data reported in this article were deposited with the GenBank Database under Accession nos. AY496263AY496267 (ARHGAP20) and AY497046AY497060 (BRWD3).Approved designation of both novel genes, ARHGAP20, at 11q23, and BRWD3, at Xq13, was obtained from the HUGO Nomenclature Committee.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 42, n. 2, p. 128, doi. 10.1002/gcc.20131
- By:
- Publication type:
- Article
Duplication of chromosome arms 9q and 11q: Evidence for a novel, 14q32 translocationindependent pathogenetic pathway in multiple myeloma.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 42, n. 1, p. 78, doi. 10.1002/gcc.20098
- By:
- Publication type:
- Article
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract.
- Published in:
- Genes, Chromosomes & Cancer, 2001, v. 31, n. 4, p. 316, doi. 10.1002/gcc.1150
- By:
- Publication type:
- Article
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2000, v. 27, n. 3, p. 285, doi. 10.1002/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M
- By:
- Publication type:
- Article
Minimal sizes of deletions detected by comparative genomic hybridization.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 21, n. 2, p. 172, doi. 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.0.CO;2-T
- By:
- Publication type:
- Article
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances.
- Published in:
- Genes, Chromosomes & Cancer, 1997, v. 20, n. 4, p. 399, doi. 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I
- By:
- Publication type:
- Article
Aging Associates with Cilium Elongation and Dysfunction in Kidney and Pancreas.
- Published in:
- Advanced Biology, 2023, v. 7, n. 12, p. 1, doi. 10.1002/adbi.202300194
- By:
- Publication type:
- Article
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0364-x
- By:
- Publication type:
- Article
CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01750-X
- By:
- Publication type:
- Article
Poster: CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01389-6
- By:
- Publication type:
- Article
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An Improved Benefit-Risk Profile of Duvelisib in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received ≥2 Prior Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S276, doi. 10.1016/j.clml.2019.07.209
- By:
- Publication type:
- Article
Effect of Dose Modifications on Response to Duvelisib in Patients with Relapsed/Refractory (R/R) CLL/SLL in the DUO Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S273, doi. 10.1016/j.clml.2019.07.204
- By:
- Publication type:
- Article